Fundraising FoxThird Rock Ventures — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Casma is a biotech company developing technology that uses the autophagy pathway to degrade disease targets for therapeutic applications.
BiotechDeep TechHealthtechBoston, US
Andrea Ballabio(Founder)Beth Levine(Founder)Herbert Virgin(Founder)James Hurley(Founder)in
Co-investorsAstellas Venture Management LLCEisai Innovation, Inc.Ono Venture Investment, Inc.The Column Group
BiotechCambridge, US
Ed Freedman(Executive Officer, Director)
BoardCary Pfeffer(Executive Officer, Director)in
PartnerCary Pfeffer· quoted
Board seatCharles HomcyRobert Tepper· per SEC Form D
Co-investorsNovartis Venture Fund
insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.
AI & Machine LearningBiotechSouth San Francisco, US
Daphne Koller(Founder)inDuane Valz(General Counsel)inMary Rozenman(Chief Financial Officer)in
BoardRobert Nelsen(Director)Vijay Pande(Director)in
Co-investorsAndreessen HorowitzARCH Venture PartnersDeviation CapitalForesite CapitalGV (Google Ventures)HOF Capital+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cedilla Therapeutics, Inc.Goldfinch BioPharmaSage Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.